Tijana Martinov

Title: Tijana Martinov: Innovator in Cancer Immunotherapy

Introduction

Tijana Martinov is a prominent inventor based in Seattle, WA, known for her significant contributions to the field of cancer immunotherapy. With a focus on targeting Ras neoantigens, her work aims to improve treatment options for cancer patients. Tijana holds 2 patents that reflect her innovative approach to medical science.

Latest Patents

Tijana's latest patents include compositions and methods for targeting Ras antigens to treat or prevent cancer. These patents disclose embodiments that involve binding proteins, such as T cell receptors or chimeric antigen receptors, which bind to a Ras antigen:HLA complex. The polynucleotides encoding these binding proteins can be introduced into host cells, such as T cells, which can then be utilized in immunotherapy for various cancers. Additionally, her patents provide immunogenic polypeptides that can induce an immune response against mutated Ras or help identify binding proteins that target Ras antigens.

Career Highlights

Tijana Martinov is affiliated with the Fred Hutchinson Cancer Center, where she conducts her research and develops her innovative ideas. Her work is instrumental in advancing the understanding and treatment of cancer through immunotherapy.

Collaborations

Tijana collaborates with notable colleagues, including Rachel Perret and Philip D. Greenberg, who contribute to her research efforts and enhance the impact of her work in the field.

Conclusion

Tijana Martinov's contributions to cancer immunotherapy through her innovative patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to pave the way for new treatment options for cancer patients.